Lakeland Cancer Center Enhances Prostate Biopsies with MRI/Ultrasound Fusion

Lakeland Regional Cancer Center (LRCC) now utilizes the UroNav fusion system to improve the accuracy of prostate biopsies. This state-of-the-art technology combines MRI and ultrasound to help physicians better analyze, plan, and target suspicious tissue.

LRCC is the first healthcare provider in the region to offer this advanced cancer detection technology. The UroNav system integrates magnetic resonance imaging (MRI) with real-time ultrasound guidance, giving doctors a clearer view of the prostate to improve detection rates of cancerous lesions and ensure biopsies occur in critical areas.

This new system offers patients more definitive diagnoses and potentially earlier intervention for prostate cancer. LRCC's adoption of the UroNav system demonstrates its commitment to providing high-quality cancer care.

Patients seeking more information or wishing to schedule an appointment can contact LRCC directly. Patient services can provide further details on the clinical benefits of the UroNav system.